Scopus (SJR) / WoS (JCR)
Pharmaceuticals
Article year 2013; shown index year 2019.
Article detail · 2013
Pharmaceuticals
YÖKSİS YÖKSİS article record
OpenAlex OpenAlex enrichment (abstract, citations, topics)
English (OpenAlex)
The rapid increase in drug-resistant infections has presented a serious challenge to antimicrobial therapies. The failure of the most potent antibiotics to kill "superbugs" emphasizes the urgent need to develop other control agents. Here we review the history and new development of antimicrobial peptides (AMPs), a growing class of natural and synthetic peptides with a wide spectrum of targets including viruses, bacteria, fungi, and parasites. We summarize the major types of AMPs, their modes of action, and the common mechanisms of AMP resistance. In addition, we discuss the principles for designing effective AMPs and the potential of using AMPs to control biofilms (multicellular structures of bacteria embedded in extracellular matrixes) and persister cells (dormant phenotypic variants of bacterial cells that are highly tolerant to antibiotics).
WoS (JCR) and Scopus (SJR) quartiles by ISSN and publication year. · 2013
Scopus (SJR) / WoS (JCR)
Article year 2013; shown index year 2019.